Hybrid Quantum–Classical Machine Learning for Sustainable Drug Discovery: Heat Capacity-Based Drug-Likeness Evaluation

DOI

https://www.doi.org/10.59256/indjcst.20260503020

Published In

Volume 5, Issue 3 (2026)

Published Online

September-December 2026

Pages

154-161

Article Type

Original Article

Check for updates

Sustainable approaches to molecular analysis can support the development of computational methods for early stage drug discovery. This work explores whether combining quantum derived molecular representations with a classical regressor improves the prediction of heat capacity, and considers what that might mean for drug-likeness assessment. The QM9 molecular dataset is first prepared through numerical preprocessing, feature scaling, and dimensionality reduction, after which the resulting representations are encoded into a quantum circuit to produce quantum-derived features. These are combined with conventional molecular descriptors and fed into an XGBoost regressor to generate the final heat-capacity (Cv) predictions. To gauge whether this hybrid design offers any real advantage, its output is compared directly against a purely classical model, using R², MAE, and MSE as the basis for comparison. The hybrid configuration reaches an R² of approximately 0.947, versus roughly 0.923 for the classical model a gap that suggests quantum-derived representations can meaningfully sharpen prediction of this thermodynamic property, at least under the conditions tested here. Overall, the framework offers a computationally grounded approach that could support molecular screening and contribute to more sustainable early-stage drug-discovery strategies.